Intezyne Technologies' Unattributed Round

Intezyne Technologies raised a round of funding on June 25, 2013.

Intezyne Technologies is dedicated to treating cancer better. Intezyne's nanotechnology platform, the IVECT(TM) Method, can be generated around a broad array of drugs, from small molecules to peptides…

Articles about Intezyne Technologies' Unattributed Round: